Cargando…

Carbapenem-resistant Enterobacterales susceptibility patterns to new antimicrobials: A single-center analysis

Background: Multidrug-resistant bacteria are of high concern, and empiric antimicrobial choice for infections caused by these pathogens, while awaiting susceptibilities, is increasingly encountered. We describe the susceptibility patterns of ceftazidime-avibactam (CZA), imipenem-rel-ebactam (I-R), m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monk, Miranda, Turbett, Sarah, Yang, Christine, Elshaboury, Ramy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Mdr Gnr
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594227/ http://dx.doi.org/10.1017/ash.2023.337

Ejemplares similares

Whole-genome sequencing of carbapenem-resistant Enterobacterales isolates and evaluation of hospital-acquired infections
por: Ajaka, Leama, et al.
Publicado: (2023)

Carbapenemase genes and mortality in patients with carbapenem-resistant Enterobacterales, Atlanta, Georgia, 2011–2020
por: Witt, Lucy, et al.
Publicado: (2023)

Identifying patients at high risk for carbapenem-resistant Enterobacterales carriage upon admission to acute-care hospitals
por: Howard-Anderson, Jessica, et al.
Publicado: (2023)

Difference in Susceptibility Between Carbapenemase- and Non–Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae
por: Clark, Justin, et al.
Publicado: (2021)

Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) in hospitalized patients in Botswana
por: Mannathoko, Naledi Betsi, et al.
Publicado: (2023)

Characterization of carbapenem-resistant gram-negative bacteria collected in the Sentinel Surveillance Program, 2018–2019
por: Spicer, Lori, et al.
Publicado: (2022)

How Does Antimicrobial Resistance Increase Medical Costs in Community-Acquired Acute Pyelonephritis?
por: Kim, Bongyoung, et al.
Publicado: (2021)

Treatment of Extensively Drug-Resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) Medical Centers
por: Fitzpatrick, Margaret, et al.
Publicado: (2021)

Predicting the regional impact of interventions to prevent and contain multidrug-resistant organisms
por: Cincotta, Samuel, et al.
Publicado: (2022)

Pseudomonas aeruginosa bacteremia mortality and resistance trends in the Veterans’ Health Administration (VHA) system
por: Hojat, Leila, et al.
Publicado: (2022)

Characteristics of patients positive for COVID-19 and multidrug-resistant organisms in Tennessee, 2020–2021
por: Stover, Carolyn, et al.
Publicado: (2022)

Evaluation of Ceftolozane/Tazobactam, Ceftazidime/Avibactam and Meropenem/Vaborbactam Against Multidrug-Resistant (MDR) Pseudomonas
por: Shamsulddin, Haider, et al.
Publicado: (2021)

Stewardship Nightmare: Ceftolozane/Tazobactam–Resistant Pseudomonas aeruginosa Infections Accelerated by the COVID-19 Pandemic
por: Haviland, Adam, et al.
Publicado: (2021)

Low function and frequent readmission in nursing home patients with persistent resistant gram-negative bacterial colonization
por: Mills, John, et al.
Publicado: (2022)

Time Above All Else: Pharmacodynamic Analysis of Β-Lactams in Critically Ill Patients
por: Landmesser, Katherine, et al.
Publicado: (2021)

Management of Pseudomonas aeruginosa Bloodstream Infection and Impact on Health Outcomes
por: Ramanathan, Swetha, et al.
Publicado: (2021)

Inpatient point-prevalence screening of New Delhi Metallo-β-lactamase (NDM)–producing Enterobacaterales and Candida auris
por: Greco, Christian, et al.
Publicado: (2022)

A retrospective longitudinal observational study of natural history of ESBL/MDR gram negative organisms in patients hospitalized in a tertiary hospital
por: Vasudeva, Shikha, et al.
Publicado: (2022)

Real-world clinical outcomes of cefiderocol therapy in the Veterans Health Administration, 2019–2022
por: Amenta, Eva, et al.
Publicado: (2023)

SG-APSIC1097: The impact of COVID-19 on the incidence of carbapenem-resistant Enterobacterales (CRE) in Singapore: An interrupted time-series analysis
por: Ong, Chong Hui Clara, et al.
Publicado: (2023)

SG-APSIC1157: The attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections—A prospective cohort study in Suva, Fiji
por: Loftus, Michael, et al.
Publicado: (2023)

SG-APSIC1159: Control of hospital-acquired carbapenemase-producing carbapenem-resistant Enterobacteriaceae colonization: A descriptive study
por: Wu, Tuodi, et al.
Publicado: (2023)

In Vitro Susceptibility to Ceftazidime-Avibactam and Comparator Antimicrobial Agents of Carbapenem-Resistant Enterobacterales Isolates
por: Lim, Tze-Peng, et al.
Publicado: (2023)

SG-APSIC1209: Risk factors associated with mortality among carbapenem-resistant Enterobacteriaceae inpatient in a tertiary-care teaching hospital in Malaysia
por: Sri Ponnampalavanar, Sasheela Sri La, et al.
Publicado: (2023)

716. Effect of Carbapenem-resistant vs. Carbapenem-susceptible Enterobacterales infections on patient outcomes at an academic medical center
por: Clark, Justin A, et al.
Publicado: (2023)

SG-APSIC1203: Detection of carbapenemase genes in donor lungs at the point of care before transplantation reduces the risk of carbapenem-resistant Enterobacteriaceae–associated donor-derived infection in lung-transplant recipients
por: Zhou, Wenyong, et al.
Publicado: (2023)

SG-APSIC1136: Multidrug-resistant organisms: Elevating issues identified by antimicrobial stewardship to improve infection control responses
por: Sheehan, Frances, et al.
Publicado: (2023)

SG-APSIC1102: Antimicrobial resistance and related factors in an intensive care unit—A study at Hue Central Hospital
por: Dang, Tan, et al.
Publicado: (2023)

SG-APSIC1096: Changes in resistance patterns of “ESKAPE” pathogens to azithromincin and levofloxacin in Yogyakarta
por: Asdie, Rizka, et al.
Publicado: (2023)

Performance Evaluation of BD Phoenix NMIC-413 Antimicrobial Susceptibility Testing Panel for Imipenem, Meropenem, and Ertapenem Against Clinical Carbapenem-Resistant and Carbapenem-Susceptible Enterobacterales
por: Zhang, Jingjia, et al.
Publicado: (2021)

Carbapenem-Resistant Enterobacterales: Considerations for Treatment in the Era of New Antimicrobials and Evolving Enzymology
por: Lasko, Maxwell J., et al.
Publicado: (2020)

Antimicrobial Activity Profiles and Potential Antimicrobial Regimens against Carbapenem-Resistant Enterobacterales Isolated from Multi-Centers in Western Thailand
por: Nulsopapon, Parnrada, et al.
Publicado: (2022)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
por: Fadlallah, Mahdi, et al.
Publicado: (2023)

588. Ceftolozane/Tazobactam Susceptibility of Carbapenem-Resistant Pseudomonas aeruginosa and Carbapenem-Resistant Enterobacterales Isolates in a Tertiary Hospital in Korea
por: Kim, Kye-Hyung, et al.
Publicado: (2023)

Synergy between infection control and antimicrobial stewardship programs to control carbapenem-resistant Enterobacterales
por: Cornistein, Wanda, et al.
Publicado: (2023)

Multiplexed paper-based assay for personalized antimicrobial susceptibility profiling of Carbapenem-resistant Enterobacterales performed in a rechargeable coffee mug
por: Oeschger, Taylor, et al.
Publicado: (2022)

2815. Outcomes of Novel Antimicrobials Compared to Polymyxin B for treatment of infections due Carbapenem-Resistant Enterobacterales Infections
por: Zheng, Tina, et al.
Publicado: (2023)

An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales
por: Rabaan, Ali A., et al.
Publicado: (2022)

SG-APSIC1083: Prevalence and classification of carbapenemase-producing gram-negative bacilli at a medical center in Ho Chi Minh City, Vietnam
por: Huynh, Tuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2dg697aq0ai7q22ok7sk3k3ifn